These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 6669829

  • 1. [Clinical pharmacology of antilipemic agents].
    Cuena Boy R, Azanza Perea JR, Honorato Pérez J.
    Rev Med Univ Navarra; 1983 Mar; 27(1):25-8. PubMed ID: 6669829
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Pharmacology and mechanism of action of etofibrate].
    Schatton W.
    Med Welt; 1982 Sep 24; 33(38):1310-4. PubMed ID: 6752630
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Drugs and high density lipoprotein metabolism.
    Packard CJ, Shepherd J.
    Health Bull (Edinb); 1982 Nov 24; 40(6):310-6. PubMed ID: 7161099
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Drug treatment of hyperlipoproteinemia].
    Chanu B.
    Soins; 1987 Jul 24; (502):21-6. PubMed ID: 3672153
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular analysis of HDL particles. Clinical applications.
    Luc G, Fruchart JC.
    Przegl Lek; 1989 Jul 24; 46(7):563-5. PubMed ID: 2685916
    [No Abstract] [Full Text] [Related]

  • 11. [Lipid lowering therapy in the elderly].
    Kaffarnik H, Schneider J.
    MMW Munch Med Wochenschr; 1983 Jul 15; 125(28):663-5. PubMed ID: 6412133
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Antilipemic drugs].
    Schwandt P.
    Med Monatsschr Pharm; 1980 Oct 15; 3(10):302-5. PubMed ID: 7007844
    [No Abstract] [Full Text] [Related]

  • 14. [A study of the effect of some hypolipidemic substances].
    Synková J.
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1978 Oct 15; 21(4):401-25. PubMed ID: 316922
    [No Abstract] [Full Text] [Related]

  • 15. Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study.
    Domingo AJ, Gutiérrez JA, Menéndez JA, Micó L, Muñoz M, de Oya M.
    Clin Ther; 1980 Oct 15; 3(3):219-26. PubMed ID: 7459931
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hypolipidemic and hypouricemic action of fenofibrate in various types of hyperlipoproteinemias.
    Harvengt C, Heller F, Desager JP.
    Artery; 1980 Oct 15; 7(1):73-82. PubMed ID: 7247733
    [Abstract] [Full Text] [Related]

  • 18. Current status of drugs used to treat hyperlipoproteinemias.
    Saunders RN, Azarnoff DL.
    Drug Ther; 1982 Oct 15; ():1-16. PubMed ID: 7049648
    [No Abstract] [Full Text] [Related]

  • 19. [Differential therapy of hyperlipoproteinemias].
    Zegenhagen R.
    Z Arztl Fortbild (Jena); 1990 Oct 15; 84(21):1093-4. PubMed ID: 2281694
    [No Abstract] [Full Text] [Related]

  • 20. [Dyslipoproteinemia of diabetes: fibrates or statins?].
    Moulin P.
    Diabetes Metab; 1999 Sep 15; 25(3):270-4. PubMed ID: 10499198
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.